ZEHNDER WILLIAM TODD 4

What Happened
William (Todd) Zehnder, COO of Viemed Healthcare (VMD), reported vesting/conversion of equity awards on January 21, 2026. The filing shows exercise/conversion of derivative/award units totaling 117,548 and 8,554 units (126,102 units total). To satisfy withholding and cash settlement: 35,075 shares were withheld by the issuer to cover taxes at $7.49 per share for $262,712, and 8,554 shares were disposed to the issuer at $7.49 per share for $64,069. The transactions reflect award vesting and cash settlement rather than an open-market sale.

Key Details

• Transaction date: January 21, 2026; Form 4 filed January 23, 2026 (appears timely).
• Prices reported: $7.49 per share (per-share value based on 1/21/2026 closing price).
• Shares involved: 117,548 and 8,554 derivative/award units (total 126,102 units reported as exercised/converted).
• Shares withheld for taxes: 35,075 @ $7.49 = $262,712 (tax withholding, code F).
• Shares disposed to issuer: 8,554 @ $7.49 = $64,069 (disposition to issuer, code D).
• Shares owned after the transactions: not stated in the provided filing details.
• Relevant footnotes: F1–F6 describe RSU/phantom-unit mechanics, tax withholding, and that some awards are cash-settled phantom shares (cash settlement reported as simultaneous acquisition and disposition).
• Transaction codes: M = exercise/conversion of derivative; F = tax withholding; D = disposition to issuer.

Context

• These entries represent routine vesting and settlement of restricted stock units and phantom (cash-settled) share units, not an open-market sell by the insider. For phantom shares, the Form 4 reports the settlement as acquiring underlying shares and immediately disposing of them back to the company for cash.
• Such filings often reflect compensation and tax-withholding mechanics rather than a change in insider sentiment; they do not necessarily indicate bullish or bearish views by the insider.